REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for Diabetes

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Type 2 Diabetes
Interventions
OTHER

Treatment Algorithms

subjects in the intervention group will receive diabetes care from a well-trained registered nurse (RN) who will follow approved treatment algorithms/protocols for glycemia, high blood pressure, lipids and microalbuminuria.

Trial Locations (1)

15213

University of Pittsburgh Medical Center Community Medicine Inc. (UPMC CMI) Primary Care Practices, Pittsburgh

All Listed Sponsors
collaborator

American Diabetes Association

OTHER

lead

University of Pittsburgh

OTHER

NCT01611168 - REMEDIES4D: REdesigning MEDication Intensification Effectiveness Study for Diabetes | Biotech Hunter | Biotech Hunter